This invention provides a solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline and particles having a non-filamentous microstructure of at least two sugar alcohols. This invention also provides a solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline a mixture of a disintegrant a flow agent and particles having a non-filamentous microstructure of at least two sugar alcohols a supplemental sugar alcohol a supplemental flow agent and a supplemental disintegrant. This invention further provides a method of treating a subject afflicted with Parkinson's disease comprising administering to the subject a therapeutically effective amount of the solid pharmaceutical composition thereby treating the subject. Finally this invention provides a process of making such solid pharmaceutical compositions.

暂无附图